Characterisation of Fundamental Decision Making in People Suffering From a Characterised Depressive Episode
Launched by UNIVERSITY HOSPITAL, TOURS · Dec 14, 2022
Trial Information
Current as of January 21, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying how people with Major Depressive Disorder (MDD) make decisions during a depressive episode. The researchers want to understand how depression affects thinking and decision-making by having participants complete various tasks that assess their mental abilities and emotional symptoms. This information could help improve treatments for depression by providing better insights into how it impacts daily life.
To be eligible for this study, participants should be between 18 and 65 years old and have been diagnosed with a depressive episode based on specific criteria. They should not have any other serious mental health conditions like bipolar disorder or schizophrenia, and there should be no signs of dementia. If you join the trial, you can expect to complete some mental tests and assessments related to your mood and anxiety. The study is currently looking for participants, and your involvement could contribute to important findings in understanding depression.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 65 years.
- • Diagnosis of a depressive episode according to DSM-5 criteria, confirmed by the Mini International Neuropsychiatric Interview (MINI 7.0 according to DSM-5).
- • No evidence of bipolar disorder or schizophrenia, confirmed by the MINI.
- • No dementing neurological disease.
- • No guardianship or trusteeship
- Exclusion Criteria:
- • Opposition to data processing
- • Depressive episode in the context of a known bipolar disorder or schizophrenic illness
Trial Officials
Wissam EL HAGE
Principal Investigator
CHU Tours
About University Hospital, Tours
The University Hospital of Tours, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative clinical research and patient-centered care. With a strong emphasis on collaboration between researchers, clinicians, and community partners, the hospital fosters a dynamic environment for conducting high-quality clinical trials across various medical disciplines. Its commitment to excellence in patient safety, ethical standards, and scientific integrity positions the University Hospital of Tours as a pivotal contributor to the development of new therapies and health solutions, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tours, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials